FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891443826> ?p ?o ?g. }

• W2891443826 endingPage "2079" @default.
• W2891443826 startingPage "2069" @default.
• W2891443826 abstract "Breast cancer is a common type of cancer among female cancer patients and the main cause of cancer-related deaths. During the last decades, targeted therapies for breast cancer have been rapidly developing. Among them, MLN4924, a first-in-class NEDD8-activating enzyme (NAE) inhibitor, has performed antitumor activity by inactivating the cullin-RING ligases and causing the accumulation of their substrates to induce apoptosis in a number of studies. In this study, we found that MLN4924 activates the AKT pathway in both HER2-positive and triple-negative breast cancer (TNBC) cell lines. Given that AKT signaling is responsible for tumor progression and drug resistance in some types of cancers, we hypothesized that the AKT inhibitor may synergistically enhance the tumor suppression capability in breast cancer by MLN4924. To demonstrate the sensitizing effect, MK-2206 was chosen as the adjuvant treatment, and cell growth, migration and apoptosis were detected. The results showed that MLN4924 treatment inhibited cell growth and migration and induced apoptosis in both SK-BR3 and MDA-MB231 breast cancer cell lines. More importantly, the combined treatment of MLN4924 and MK-2206 indeed caused stronger cytotoxicity and inhibition of migration and a much higher induction of apoptosis compared with MLN4924 treatment alone. Our study provides the proof-of-concept evidence for strategic drug combination of MLN4924 with an AKT inhibitor for maximal killing of breast cancer cells via the enhancement of apoptosis." @default.
• W2891443826 created "2018-09-27" @default.
• W2891443826 creator A5015917699 @default.
• W2891443826 creator A5039601252 @default.
• W2891443826 creator A5043094856 @default.
• W2891443826 creator A5059411979 @default.
• W2891443826 creator A5066991154 @default.
• W2891443826 creator A5089045244 @default.
• W2891443826 date "2018-08-18" @default.
• W2891443826 modified "2023-10-05" @default.
• W2891443826 title "AKT inhibitor MK-2206 sensitizes breast cancer cells to MLN4924, a first-in-class NEDD8-activating enzyme (NAE) inhibitor" @default.
• W2891443826 cites W1271389891 @default.
• W2891443826 cites W152279435 @default.
• W2891443826 cites W1955456147 @default.
• W2891443826 cites W1968887194 @default.
• W2891443826 cites W1973777839 @default.
• W2891443826 cites W1974081053 @default.
• W2891443826 cites W1985593766 @default.
• W2891443826 cites W2018041853 @default.
• W2891443826 cites W2020430280 @default.
• W2891443826 cites W2044702943 @default.
• W2891443826 cites W2054940324 @default.
• W2891443826 cites W2063342763 @default.
• W2891443826 cites W2065919583 @default.
• W2891443826 cites W2066013154 @default.
• W2891443826 cites W2066745745 @default.
• W2891443826 cites W2068812984 @default.
• W2891443826 cites W2076194625 @default.
• W2891443826 cites W2081010886 @default.
• W2891443826 cites W2097255042 @default.
• W2891443826 cites W2101083009 @default.
• W2891443826 cites W2103563357 @default.
• W2891443826 cites W2122481965 @default.
• W2891443826 cites W2127063807 @default.
• W2891443826 cites W2128248939 @default.
• W2891443826 cites W2132485651 @default.
• W2891443826 cites W2144051719 @default.
• W2891443826 cites W2150174916 @default.
• W2891443826 cites W2157158866 @default.
• W2891443826 cites W2159750196 @default.
• W2891443826 cites W2166761147 @default.
• W2891443826 cites W2259802687 @default.
• W2891443826 cites W2321872504 @default.
• W2891443826 cites W2327195911 @default.
• W2891443826 cites W2327334027 @default.
• W2891443826 cites W2349288993 @default.
• W2891443826 cites W2560367415 @default.
• W2891443826 cites W2588368010 @default.
• W2891443826 cites W2612662853 @default.
• W2891443826 cites W2751309406 @default.
• W2891443826 cites W2781525129 @default.
• W2891443826 cites W2784179760 @default.
• W2891443826 doi "https://doi.org/10.1080/15384101.2018.1515550" @default.
• W2891443826 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6224269" @default.
• W2891443826 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30198810" @default.
• W2891443826 hasPublicationYear "2018" @default.
• W2891443826 type Work @default.
• W2891443826 sameAs 2891443826 @default.
• W2891443826 citedByCount "17" @default.
• W2891443826 countsByYear W28914438262020 @default.
• W2891443826 countsByYear W28914438262021 @default.
• W2891443826 countsByYear W28914438262022 @default.
• W2891443826 countsByYear W28914438262023 @default.
• W2891443826 crossrefType "journal-article" @default.
• W2891443826 hasAuthorship W2891443826A5015917699 @default.
• W2891443826 hasAuthorship W2891443826A5039601252 @default.
• W2891443826 hasAuthorship W2891443826A5043094856 @default.
• W2891443826 hasAuthorship W2891443826A5059411979 @default.
• W2891443826 hasAuthorship W2891443826A5066991154 @default.
• W2891443826 hasAuthorship W2891443826A5089045244 @default.
• W2891443826 hasBestOaLocation W28914438261 @default.
• W2891443826 hasConcept C121608353 @default.
• W2891443826 hasConcept C190283241 @default.
• W2891443826 hasConcept C2777408456 @default.
• W2891443826 hasConcept C31573885 @default.
• W2891443826 hasConcept C502942594 @default.
• W2891443826 hasConcept C530470458 @default.
• W2891443826 hasConcept C54355233 @default.
• W2891443826 hasConcept C55493867 @default.
• W2891443826 hasConcept C75217442 @default.
• W2891443826 hasConcept C86803240 @default.
• W2891443826 hasConcept C96232424 @default.
• W2891443826 hasConceptScore W2891443826C121608353 @default.
• W2891443826 hasConceptScore W2891443826C190283241 @default.
• W2891443826 hasConceptScore W2891443826C2777408456 @default.
• W2891443826 hasConceptScore W2891443826C31573885 @default.
• W2891443826 hasConceptScore W2891443826C502942594 @default.
• W2891443826 hasConceptScore W2891443826C530470458 @default.
• W2891443826 hasConceptScore W2891443826C54355233 @default.
• W2891443826 hasConceptScore W2891443826C55493867 @default.
• W2891443826 hasConceptScore W2891443826C75217442 @default.
• W2891443826 hasConceptScore W2891443826C86803240 @default.
• W2891443826 hasConceptScore W2891443826C96232424 @default.
• W2891443826 hasFunder F4320321001 @default.
• W2891443826 hasFunder F4320338464 @default.
• W2891443826 hasIssue "16" @default.
• W2891443826 hasLocation W28914438261 @default.
• W2891443826 hasLocation W28914438262 @default.

• next